Operating Lease, Right-of-Use Asset of Praxis Precision Medicines, Inc. from 31 Dec 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Praxis Precision Medicines, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2019 to 31 Dec 2025.
  • Praxis Precision Medicines, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2025 was $92,000, a 92% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Praxis Precision Medicines, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $92,000 -$1,039,000 -92% 31 Dec 2025 10-K 19 Feb 2026 2025 FY
Q3 2025 $362,000 -$1,012,000 -74% 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $626,000 -$984,000 -61% 30 Jun 2025 10-Q 04 Aug 2025 2025 Q2
Q1 2025 $882,000 -$958,000 -52% 31 Mar 2025 10-Q 02 May 2025 2025 Q1
Q4 2024 $1,131,000 -$933,000 -45% 31 Dec 2024 10-K 19 Feb 2026 2025 FY
Q3 2024 $1,374,000 -$908,000 -40% 30 Sep 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 $1,610,000 -$884,000 -35% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 $1,840,000 -$860,000 -32% 31 Mar 2024 10-Q 13 May 2024 2024 Q1
Q4 2023 $2,064,000 -$837,000 -29% 31 Dec 2023 10-K 28 Feb 2025 2024 FY
Q3 2023 $2,282,000 -$815,000 -26% 30 Sep 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 $2,494,000 -$793,000 -24% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 $2,700,000 -$773,000 -22% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $2,901,000 -$752,000 -21% 31 Dec 2022 10-K 05 Mar 2024 2023 FY
Q3 2022 $3,097,000 -$931,000 -23% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 $3,287,000 -$1,113,000 -25% 30 Jun 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 $3,473,000 +$2,902,000 +508% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 $3,653,000 +$2,899,000 +384% 31 Dec 2021 10-K 07 Feb 2023 2022 FY
Q3 2021 $4,028,000 +$3,095,000 +332% 30 Sep 2021 10-Q 03 Nov 2021 2021 Q3
Q2 2021 $4,400,000 30 Jun 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 $571,000 31 Mar 2021 10-Q 11 May 2021 2021 Q1
Q4 2020 $754,000 -$696,000 -48% 31 Dec 2020 10-K 28 Feb 2022 2021 FY
Q3 2020 $933,000 30 Sep 2020 10-Q 23 Nov 2020 2020 Q3
Q4 2019 $1,450,000 31 Dec 2019 10-K 17 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.